Eli Lilly’s daily GLP-1 pill shows strong weight loss results without food restrictions |
Recent Views 9 In the first Phase 3 trial of its once-daily oral GLP-1 pill for obesity, drugmaker Eli Lilly reported that participants lost an average of 12% of their body weight after 72 weeks. The findings, announced Thursday in a company news release, come from a study of more than 3,127 adults who were…

